Tango Therapeutics
TNGX
TNGX
100 hedge funds and large institutions have $1,000M invested in Tango Therapeutics in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 26 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
12% more funds holding
Funds holding: 89 → 100 (+11)
10.02% more ownership
Funds ownership: 77.28% → 87.3% (+10%)
Holders
100
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$62.3M | |
| 2 | +$52.6M | |
| 3 | +$27.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.4M |
| 5 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$10.9M |
Top Sellers
| 1 | -$1.97M | |
| 2 | -$1.03M | |
| 3 | -$731K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$548K |
| 5 |
Renaissance Technologies
New York
|
-$456K |